Cargando…

Exercise changes the intrahepatic immune cell profile and inhibits the progression of nonalcoholic steatohepatitis in a mouse model

BACKGROUND: NASH is an increasingly common cause of chronic liver disease and can progress to cirrhosis and HCC. Although exercise suppresses inflammation during acute hepatitis, its impact on the progression of chronic liver disease remains unclear. Here, we investigated the effects of exercise on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsutsui, Yuriko, Mori, Taizo, Yoshio, Sachiyo, Sato, Miku, Sakata, Toshihiro, Yoshida, Yuichi, Kawai, Hironari, Yoshikawa, Shiori, Yamazoe, Taiji, Matsuda, Michitaka, Kakazu, Eiji, Osawa, Yosuke, Oyama, Chinatsu, Tamura-Nakano, Miwa, Kawaguchi, Takumi, Yoshizumi, Tomoharu, Kanto, Tatsuya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531194/ https://www.ncbi.nlm.nih.gov/pubmed/37756046 http://dx.doi.org/10.1097/HC9.0000000000000236

Ejemplares similares

Blood angiopoietin-2 predicts liver angiogenesis and fibrosis in hepatitis C patients
por: Osawa, Yosuke, et al.
Publicado: (2021)

Cluster of Differentiation 44 Promotes Liver Fibrosis and Serves as a Biomarker in Congestive Hepatopathy
por: Osawa, Yosuke, et al.
Publicado: (2021)

Phenotypic Characterization by Single-Cell Mass Cytometry of Human Intrahepatic and Peripheral NK Cells in Patients with Hepatocellular Carcinoma
por: Yoshida, Yuichi, et al.
Publicado: (2021)

Serum milk fat globule-EGF factor 8 (MFG-E8) as a diagnostic and prognostic biomarker in patients with hepatocellular carcinoma
por: Shimagaki, Tomonari, et al.
Publicado: (2019)

Increased Frequency of Dysfunctional Siglec-7(−)CD57(+)PD-1(+) Natural Killer Cells in Patients With Non-alcoholic Fatty Liver Disease
por: Sakamoto, Yuzuru, et al.
Publicado: (2021)

Immune Determinants in the Acquisition and Maintenance of Antibody to Hepatitis B Surface Antigen in Adults After First‐Time Hepatitis B Vaccination
por: Doi, Hiroyoshi, et al.
Publicado: (2019)

Impact of JMJD6 on intrahepatic cholangiocarcinoma
por: Kosai-Fujimoto, Yukiko, et al.
Publicado: (2022)

Differential Intrahepatic Phospholipid Zonation in Simple Steatosis and Nonalcoholic Steatohepatitis
por: Wattacheril, Julia, et al.
Publicado: (2013)

CXCL12 expression in intrahepatic cholangiocarcinoma is associated with metastasis and poor prognosis
por: Miyata, Tatsunori, et al.
Publicado: (2019)

Case: Authentic multimodal therapy and liver resection for an initially unresectable intrahepatic cholangiocarcinoma
por: Sakata, Koichiro, et al.
Publicado: (2018)

Recombinant SFRP5 protein significantly alleviated intrahepatic inflammation of nonalcoholic steatohepatitis
por: Chen, Lili, et al.
Publicado: (2017)

Primary intrahepatic cholangiocarcinoma with sarcomatous stroma: case report and review of the literature
por: Yugawa, Kyohei, et al.
Publicado: (2018)

Non-Alcoholic Steatohepatitis as a Risk Factor for Intrahepatic Cholangiocarcinoma and Its Prognostic Role
por: De Lorenzo, Stefania, et al.
Publicado: (2020)

Hepatitis Action Plan and Changing Trend of Liver Disease in Japan: Viral Hepatitis and Nonalcoholic Fatty Liver Disease
por: Kanto, Tatsuya, et al.
Publicado: (2017)

Antidiabetic Therapy in the Treatment of Nonalcoholic Steatohepatitis
por: Sumida, Yoshio, et al.
Publicado: (2020)

Obesity is a risk factor for intrahepatic cholangiocarcinoma progression associated with alterations of metabolic activity and immune status
por: Yugawa, Kyohei, et al.
Publicado: (2021)

Quantification of DNA methylation for carcinogenic risk estimation in patients with non-alcoholic steatohepatitis
por: Kuramoto, Junko, et al.
Publicado: (2022)

Metabolic pathways promoting intrahepatic fatty acid accumulation in methionine and choline deficiency: implications for the pathogenesis of steatohepatitis
por: Macfarlane, David P., et al.
Publicado: (2011)

Liver X Receptor Inverse Agonist SR9243 Suppresses Nonalcoholic Steatohepatitis Intrahepatic Inflammation and Fibrosis
por: Huang, Peng, et al.
Publicado: (2018)

Modulating sphingosine 1-phosphate receptor signaling skews intrahepatic leukocytes and attenuates murine nonalcoholic steatohepatitis
por: Liao, Chieh-Yu, et al.
Publicado: (2023)

Wilson's disease masquerading as nonalcoholic steatohepatitis
por: Mahmood, Sabina, et al.
Publicado: (2009)

Cancer‐associated fibroblasts promote tumor cell growth via miR‐493‐5p in intrahepatic cholangiocarcinoma
por: Toshida, Katsuya, et al.
Publicado: (2022)

Gene-regulation modules in nonalcoholic fatty liver disease revealed by single-nucleus ATAC-seq
por: Takeuchi, Fumihiko, et al.
Publicado: (2023)

Tumor necrosis factor‐α‐mediated hepatocyte apoptosis stimulates fibrosis in the steatotic liver in mice
por: Osawa, Yosuke, et al.
Publicado: (2018)

A third dose of the BNT162b2 mRNA vaccine sufficiently improves the neutralizing activity against SARS-CoV-2 variants in liver transplant recipients
por: Tomiyama, Takahiro, et al.
Publicado: (2023)

Correction to: Portal flow modulation in living donor liver transplantation: review with a focus on splenectomy
por: Yoshizumi, Tomoharu, et al.
Publicado: (2020)

Portal flow modulation in living donor liver transplantation: review with a focus on splenectomy
por: Yoshizumi, Tomoharu, et al.
Publicado: (2019)

What Are the Precursor and Early Lesions of Peripheral Intrahepatic Cholangiocarcinoma?
por: Nakanuma, Yasuni, et al.
Publicado: (2014)

C‐reactive protein : albumin ratio in patients with resectable intrahepatic cholangiocarcinoma
por: Matsumoto, T., et al.
Publicado: (2020)

The authors’ reply: Indispensable discrepancy between predicted graft “volume” and actual graft “weight” in clinical practice in living‐donor liver transplantation
por: Toshima, Takeo, et al.
Publicado: (2021)

Two-dimensional shear wave elastography and ultrasound-guided attenuation parameter for progressive non-alcoholic steatohepatitis
por: Kuroda, Hidekatsu, et al.
Publicado: (2021)

p27 Is a Critical Prognostic Biomarker in Non-Alcoholic Steatohepatitis-Related Hepatocellular Carcinoma
por: Matsuda, Yasunobu, et al.
Publicado: (2013)

High Prevalence of Autoimmune Gastritis in Patients with Nonalcoholic Steatohepatitis
por: Kawanaka, Miwa, et al.
Publicado: (2019)

Identification of Human Walking Balance Controller Based on COM-ZMP Model of Humanoid Robot
por: Yoshikawa, Taizo
Publicado: (2022)

A low‐intensity 10‐min resistance exercise program that ameliorated hepatic fibrosis indices and altered G‐CSF/IP‐10/PDGF‐BB in a patient with nonalcoholic fatty liver disease: A case report
por: Hashida, Ryuki, et al.
Publicado: (2023)

Social Interactions of Juvenile Brown Boobies at Sea as Observed with Animal-Borne Video Cameras
por: Yoda, Ken, et al.
Publicado: (2011)

Modulation of Nqo1 activity intercepts anoikis resistance and reduces metastatic potential of hepatocellular carcinoma
por: Shimokawa, Masahiro, et al.
Publicado: (2020)

A Genetic Score Associates With Pioglitazone Response in Patients With Non-alcoholic Steatohepatitis
por: Kawaguchi-Suzuki, Marina, et al.
Publicado: (2018)

Treatment of nonalcoholic steatohepatitis with vitamins E and C: a pilot study
por: Kawanaka, Miwa, et al.
Publicado: (2013)

Fibrogenesis and Carcinogenesis in Nonalcoholic Steatohepatitis (NASH): Involvement of Matrix Metalloproteinases (MMPs) and Tissue Inhibitors of Metalloproteinase (TIMPs)
por: Okazaki, Isao, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_51s5u9ei61s4gimfl9lbs5svjd